Your browser doesn't support javascript.
loading
Predictors of progression in untreated keratoconus: a Save Sight Keratoconus Registry study.
Ferdi, Alex; Nguyen, Vuong; Kandel, Himal; Tan, Jeremy C K; Arnalich-Montiel, Francisco; Abbondanza, Marco; Watson, Stephanie.
Afiliação
  • Ferdi A; The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia alexander.ferdi@sydney.edu.au.
  • Nguyen V; The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia.
  • Kandel H; The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia.
  • Tan JCK; Ophthalmology, Prince of Wales Hospital, Sydney, New South Wales, Australia.
  • Arnalich-Montiel F; Cornea & External Eye Diseases, Hospital Universitario Ramón y Cajal Biblioteca, Madrid, Spain.
  • Abbondanza M; Abbondanza Eye Center, Rome, Italy.
  • Watson S; The University of Sydney Save Sight Institute, Sydney, New South Wales, Australia.
Br J Ophthalmol ; 106(9): 1206-1211, 2022 09.
Article em En | MEDLINE | ID: mdl-33785509
ABSTRACT

AIMS:

We set out to identify risk factors for progression in untreated keratoconus patients from 34 centres across Australia, New Zealand, Spain and Italy.

METHODS:

Patients were divided into 'progressors' and 'stable' patients for each clinical parameter visual acuity (VA), steepest keratometry (maximum keratometry (Max-K)) and thinnest corneal thickness (TCT). Primary outcomes were the proportion of eyes with sustained progression in VA, Max-K or TCT within 3 years. Secondary outcomes included predictors of progression.

RESULTS:

There were 3994 untreated eyes from 2283 patients. The proportion of eyes with VA, Max-K and TCT progression at 1 year were 3.2%, 6.6% and 3.1% respectively. Factors associated with VA loss were higher baseline VA (HR 1.15 per logMAR line increase in VA; p<0.001) and steeper baseline Max-K (HR 1.07 per 1D increase; p<0.001). Younger baseline age was associated with Max-K steepening (HR 0.96 per year older; p=0.001). Thicker baseline TCT, steeper baseline Max-K and younger baseline age were associated with TCT thinning (HR 1.08 per 10 µm increase in TCT; p<0.001), (HR 1.03 per 1D increase; p=0.02) and (HR 0.98 per year younger; p=0.01), respectively.

CONCLUSIONS:

Steeper Max-K and younger age were the most clinically useful baseline predictors of progression as they were associated with worsening of two clinical parameters. Every 1D steeper Max-K was associated with a 7% and 3% greater risk of worsening VA and thinning TCT, respectively. Each 1 year younger was associated with a 4% and 2% greater risk of steepening Max-K and thinning TCT, respectively.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fotoquimioterapia / Ceratocone Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Ophthalmol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fotoquimioterapia / Ceratocone Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Ophthalmol Ano de publicação: 2022 Tipo de documento: Article